PolyPeptide Group AG's market cap is currently CHF858.81M. The company's EPS TTM is CHF-0.80225229084; its P/E ratio is ―; PolyPeptide Group AG is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is CHF0.29. See an overview of income statement, balance sheet, and cash flow financials.
